drugset / Trial / NCT07365514
Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The goal of this clinical trial is to evaluate the effects of blackcurrant (BC) supplementation on changes in bone density and gut microbiome composition in postmenopausal females.
Timeline
- Start
- 2026-02-01
- Primary completion
- 2028-02
- Completion
- 2029-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Blackcurrant (BC) extract | Unknown | 784 mg | — |
| Comparator | Blackcurrant (BC) extract | Unknown | 1176 mg | — |